Scleroderma in Guinea’s African: Epidemiological, Clinical and Therapeutic Aspects
- 1 Internal Medicine Department, Donka National Hospital/University Gamal Abdel Nasser of Conakry, Conakry, Guinea
- 2 Internal Medicine Department, Donka National Hospital/University Gamal Abdel Nasser of Conakry, Conakry, Guinea
- 3 Dermatology Venerology Department, Donka National Hospital/University Gamal Abdel Nasser of Conakry, Conakry, Guinea
- 4 Internal Medicine Department, Donka National Hospital/University Gamal Abdel Nasser of Conakry, Conakry, Guinea
- 5 Internal Medicine Department, Donka National Hospital/University Gamal Abdel Nasser of Conakry, Conakry, Guinea
- 6 Dermatology Venerology Department, Donka National Hospital/University Gamal Abdel Nasser of Conakry, Conakry, Guinea
- 7 Dermatology Venerology Department, Donka National Hospital/University Gamal Abdel Nasser of Conakry, Conakry, Guinea
- 8 Dermatology Venerology Department, Donka National Hospital/University Gamal Abdel Nasser of Conakry, Conakry, Guinea
- 9 Dermatology Venerology Department, Donka National Hospital/University Gamal Abdel Nasser of Conakry, Conakry, Guinea
Abstract
Introduction: Scleroderma is a generalized condition of the connective tissue, arterioles and micro-vessels characterized by tissue fibrosis, vascular obliteration and abnormal humoral and cellular immune responses. The aim of this study was to describe the epidemiological, clinical, therapeutic and evolutionary aspects of scleroderma at the Department of Dermatology-Venerology at Donka National Hospital. Methods: This was a descriptive cross-sectional study with a retrospective collection of data for a period of 11 years, from January 1, 2000, to December 31, 2010, covering all inpatient records of Scleroderma in the service. Results: We collected 17 cases of scleroderma out of 3289, a frequency of 0.04%. The average age of patients was 33.33 years with extremes of 10 and 60 years. A female predominance was noted with a sex ratio M/F of 0.13. Cutaneous induration was the main symptom associated with the phenomenon of Raynaud, and disorders of pigmentation. The extra-skin manifestations were mainly dominated by gastrointestinal involvement (32%), pulmonary involvement (24%), cardiac (20%), articular (20%) and renal (12%) involvement. The systemic form was the most common (99.45%). Corticotherapy was the most prescribed treatment (24.59%). Clinical improvement was noted in (93.2%) of the cases. Conclusion: Scleroderma, although rare, deserves special attention at all levels for early diagnosis.
- Bonafe, J., Cambon, L. and Determe, I. (1996) What Is Your Diagnosis: Localized Scleroderma? Dermatological News, 15, 85-86.
- Saurat, J.-H., Lachapelle, J.-M., Lipsker, D., Thomas, L. and Borradori, L. (2009) Dermatology and Sexually Transmitted Infection. 5th Edition, Elsevier Masson, Paris, 1152.
- Magnant, J. and Doit, E. (2006) Systemic Scleroderma: Epidemiology and Environmental Factors. La Presse Médicale, 35, 1894-1901. https://doi.org/10.1016/S0755-4982(06)74923-5
- Roberts-Thomson, P.J. and Walker, J.G. (2006) Scleroderma: It Has Been a Long Hard Journey. Internal Medicine Journal, 36, 519-523. https://doi.org/10.1111/j.1445-5994.2006.01138.x
- Tamaki, T., Mori, S. and Takehara, K. (1991) Epidemiological Study of Patients with Systemic Sclerosis in Tokyo. Archives of Dermatological Research, 283, 366-371. https://doi.org/10.1007/BF00371817
- El Fekih, N., Rejaibi, I., Kamoun, H., Faten, Z., Fazaa, B., Kharfi, M., et al. (2009) Localized Scleroderma: A Retrospective Study of 92 Cases. Medical Tunisia, 87, 573-578.
- Yedomon, H.G. and Do-Ango-Padonou, F. (1991) Scleroderma Epidemiologic Study of 20 Cases. Medicine of Black Africa, 38, 491-496.
- Diop, A., et al. (2014) Systemic Scleroderma on Black Skin: A Series of 117 Cases. Annals of Dermatology and Venereology, 141, S470. https://doi.org/10.1016/j.annder.2014.09.539
- Ouédraogo, D.D., et al. (2014) Connectivities in Hospital Practice in Ouagadougou (Burkina Faso). Tropical Medicine and Health, 24, 271-274.
- Tamby, M.C., Chanseaud, Y., Guillevin, L. and Mouthon, L. (2003) New Insights into Pathogenesis of Systemic Sclerosis. Autoimmunity Reviews, 2, 152-157. https://doi.org/10.1016/S1568-9972(03)00004-1
- Lee, N., Furst, D.E., Maloney, S., Gooley, T., Evans, P.C., Smith, A., et al. (1997) Microchimerism and HLA-Compatible Relationships of Pregnancy in Scleroderma. Lancet, 351, 559-562.
- Artlett, C.M., Smith, J.B. and Jimenez, S.A. (1998) Identification of Fetal DNA and Cells in Skins Lesions from Women with Systemic Sclerosis. New England Journal of Medicine, 338, 1186-1191. https://doi.org/10.1056/NEJM199804233381704
- Hachulla, M., et al. (2004) Systemic Scleroderma: Clinical Polymorphism and Therapeutic Aspects. Therapeutic Medicine, 25, 316-325.
- Missounga, L. (2017) Mixed Connectivity: Prevalence and Clinical Features in African Black, A Case Study in Gabon and a Review of the Literature. Pan African Medical Journal, 27, 162.